Consistent with this, using both human and murine glioma models, we found that enforced expression of IL-33 results in the conversion of relatively immune inert glioma to a glioma with an immune rich environment that mediates rapid tumor growth and dramatic decrease in overall survival. The gene discussed is IL33; the disease is neoplasm.